Antitumor anthracycline glycosides, their preparation, intermedi

Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 64, 536 53, 536122, A61K 3171, C07H 1522

Patent

active

043930522

ABSTRACT:
Novel antitumor anthracycline glycosides are prepared by condensing daunomycinone with 2,3,4,6-tetradeoxy-4-C-methylene-3-trifluoroacetamido-L-threo-hexopyranosy l chloride; 2,3,4,6-tetradeoxy-4-C-methylene-3-trifluoroacetamido-L-arabino-hexopyrano syl chloride or 2,3,6-trideoxy-4-C-trifluoroacetamidomethyl-3-trifluoroacetamido-3-O-trifl uoroacetyl-L-lyxo-hexopyranosyl chloride.

REFERENCES:
patent: 4020270 (1977-04-01), Arcamone et al.
patent: 4039663 (1977-08-01), Arcamone et al.
patent: 4067969 (1978-01-01), Penco et al.
patent: 4265885 (1981-05-01), Bargiotti et al.
patent: 4325946 (1982-04-01), Bargiotti et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antitumor anthracycline glycosides, their preparation, intermedi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor anthracycline glycosides, their preparation, intermedi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor anthracycline glycosides, their preparation, intermedi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-198416

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.